Abstract

BackgroundIt is incompletely understood how cigarette smoke (CS) exposure affects lung mucosal immune responses during viral respiratory infections. B cell activating factor belonging to the tumor necrosis factor family (BAFF) plays an important role in the induction of secretory immunoglobulin A (S-IgA) which is the main effector of the mucosal immune system. We therefore investigated the effects of CS exposure on BAFF expression and S-IgA responses in the lung during influenza virus infection.MethodsMice were exposed to CS and/or infected with influenza virus. Bronchoalveolar lavage fluid and lung compartments were analyzed for BAFF expression, influenza-specific S-IgA level and histological changes. Lung B cells were isolated and the activation-induced cytidine deaminase (Aicda) expression was determined. BEAS-2B cells were treated with CS extract (CSE), influenza virus, interferon beta or N-acetylcysteine and BAFF expression was measured.ResultsCS inhibited BAFF expression in the lung, particularly after long-term exposure. BAFF and S-IgA levels were increased during influenza virus infection. Three-month CS exposure prior to influenza virus infection resulted in reduced BAFF and S-IgA levels in the lung as well as augmented pulmonary inflammation on day 7 after infection. Prior CS exposure also caused decreased Aicda expression in lung B cells during infection. Neutralization of BAFF in the lung resulted in reduced S-IgA levels during influenza virus infection. CSE inhibited virus-mediated BAFF induction in a dose-dependent manner in BEAS-2B cells, while this inhibition of BAFF by CSE was prevented by pretreatment with the antioxidant N-acetylcysteine.ConclusionsOur findings indicate that CS may hinder early mucosal IgA responses in the lung during influenza virus infection through oxidative inhibition of BAFF, which might contribute to the increased incidence and severity of viral infections in smokers.Electronic supplementary materialThe online version of this article (doi:10.1186/s12931-015-0201-y) contains supplementary material, which is available to authorized users.

Highlights

  • It is incompletely understood how cigarette smoke (CS) exposure affects lung mucosal immune responses during viral respiratory infections

  • IgA can be rapidly produced through the faster T cell-independent (TI) pathway involving B cell activating factor belonging to the tumor necrosis factor family (BAFF) [9,10]

  • We found that keratinocyte-derived chemokine (KC) in the lung and the total leukocyte counts in bronchoalveolar lavage (BAL) fluid were increased during infection, and both peaked on day 7 and declined significantly on day 14 (Figure 2A and B)

Read more

Summary

Introduction

It is incompletely understood how cigarette smoke (CS) exposure affects lung mucosal immune responses during viral respiratory infections. B cell activating factor belonging to the tumor necrosis factor family (BAFF) plays an important role in the induction of secretory immunoglobulin A (S-IgA) which is the main effector of the mucosal immune system. We investigated the effects of CS exposure on BAFF expression and S-IgA responses in the lung during influenza virus infection. Wang et al Respiratory Research (2015) 16:37 It is incompletely understood how CS exposure affects mucosal immune responses during respiratory infections. IgA can be rapidly produced through the faster TI pathway involving B cell activating factor belonging to the tumor necrosis factor family (BAFF) [9,10]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call